Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
← Tools
Tools · FilingsUpdated with new filings

Japan AGM Voting Results & Director Approval

Annual meeting voting results, director support and shareholder dissent.

Data through · Updated with new filings

0

board nominees with under 80% support at 2026 meetings

The lowest was Rohto Pharmaceutical's nominee at 89.42%.

Lowest director approval

1
Download CSVAll selected filings

1 meeting · 14 board nominees, each meeting's lowest approval first

The line marks 80% approval.

Lowest director approval
DirectorProposalApprovalResultFiling
山田 邦雄+13 other nominees, 91.48%–99.22%Rohto Pharmaceutical4527 · ロート製薬Election of 14 directors
Original (Japanese)取締役14名選任の件
89.42%Votes cast: 89.68% · For 1,781,901 / Against 199,559 / Abstain 5,500ApprovedFiled  — filing S100YLZB

Rejected proposals

8
Rejected proposals
CompanyProposalApprovalResultFiling
Rohto Pharmaceutical4527 · ロート製薬Dismissal of 1 director(s)Machine translated
Original (Japanese)取締役1名解任の件
11.20%†Votes cast: 11.20% · For 222,456 / Against 1,763,689 / Abstain 825RejectedFiled  — filing S100YLZB
Rohto Pharmaceutical4527 · ロート製薬Amendment of the articles of incorporation regarding the establishment of a Strategy Review CommitteeMachine translated
Original (Japanese)戦略検討委員会の設置に関する定款変更の件
8.98%†Votes cast: 8.98% · For 178,453 / Against 1,807,701 / Abstain 825RejectedFiled  — filing S100YLZB
Rohto Pharmaceutical4527 · ロート製薬Amendment of the Articles of Incorporation regarding the decision-making body for dividends of surplus, etc.Machine translated
Original (Japanese)剰余金の配当等の決定機関に関する定款変更の件
48.17%†Votes cast: 48.17% · For 957,061 / Against 1,029,092 / Abstain 825RejectedFiled  — filing S100YLZB
Rohto Pharmaceutical4527 · ロート製薬Matter of repurchase of the company's own sharesMachine translated
Original (Japanese)自己株式取得の件
11.14%†Votes cast: 11.14% · For 221,346 / Against 1,764,807 / Abstain 825RejectedFiled  — filing S100YLZB
Rohto Pharmaceutical4527 · ロート製薬Approval of the remuneration amount under the restricted stock compensation systemMachine translated
Original (Japanese)譲渡制限付株式報酬制度に関する報酬額承認の件
17.40%†Votes cast: 17.40% · For 345,736 / Against 1,640,381 / Abstain 825RejectedFiled  — filing S100YLZB
Rohto Pharmaceutical4527 · ロート製薬Amendment of the articles of incorporation regarding the composition of outside directorsMachine translated
Original (Japanese)社外取締役の構成に関する定款変更の件
15.01%†Votes cast: 15.01% · For 298,246 / Against 1,686,969 / Abstain 1,741RejectedFiled  — filing S100YLZB
Rohto Pharmaceutical4527 · ロート製薬Amendment of the Articles of Incorporation regarding measures toward realizing management that takes into account the cost of capital and share priceMachine translated
Original (Japanese)資本コストや株価を意識した経営の実現に向けた対応に関する定款変更の件
13.56%†Votes cast: 13.56% · For 269,449 / Against 1,716,684 / Abstain 825RejectedFiled  — filing S100YLZB
Rohto Pharmaceutical4527 · ロート製薬Matter regarding amendment of the Articles of Incorporation concerning the record date of the annual general meeting of shareholdersMachine translated
Original (Japanese)定時株主総会の基準日に関する定款変更の件
9.45%†Votes cast: 9.45% · For 187,808 / Against 1,798,343 / Abstain 825RejectedFiled  — filing S100YLZB

Shareholder proposals ≥ 20%

1
Shareholder proposals ≥ 20%
CompanyProposalApprovalResultFiling
Rohto Pharmaceutical4527 · ロート製薬Amendment of the Articles of Incorporation regarding the decision-making body for dividends of surplus, etc.Machine translated
Original (Japanese)剰余金の配当等の決定機関に関する定款変更の件
48.17%†Votes cast: 48.17% · For 957,061 / Against 1,029,092 / Abstain 825RejectedFiled  — filing S100YLZB

Approval is the ratio the company states (usually of the voting rights of shareholders present); votes cast are for ÷ (for + against + abstain).

† Percentage of votes cast; company did not state a ratio.

† Company-stated ratio differs from tallied votes.

All tools →